Researchers want to boost the effectiveness of current cancer treatments by regaining the immune system’s capacity to identify and combat cancer cells by inhibiting IDO or TDO activity (Sun et al., 2025; Qiao et al., 2025; Dai et al., 2025). Here, TDO2 is linked to cancer.